DoD Lupus Research, Impact Award

Background
The U.S. Army Medical Research Acquisition Activity (USAMRAA) is soliciting applications to the fiscal year 2024 (FY24) Lupus Research Program (LRP) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC) is the program management agent for this funding opportunity. The LRP’s mission is to fund research to understand, prevent, and diagnose lupus and to improve treatments and quality of life of patients, including Service Members and their Families, Veterans, and the general public.

The LRP’s vision is to cure lupus through partnership of scientists, clinicians, and consumers.

Grant Details
The LRP IPA encourages applications that support the full spectrum of research projects or ideas that specifically focus on scientific and clinical lupus issues, which, if successfully addressed, have the potential to make a major impact in lupus research and/or lupus disease.

Applications should include a well-formulated, testable hypothesis based on strong scientific rationale that is established through inferential reasoning and/or critical review and analysis of the literature. Inclusion of preliminary data is encouraged.

The LRP welcomes applicants new to the field of lupus research with novel and innovative ideas for interventions that have the potential to make a significant impact in the lives of individuals with lupus.

Eligibility Requirements
Extramural and Intramural organizations are eligible to apply, including foreign or domestic organizations, for-profit and non-profit organizations, and public entities.

Independent investigators at or above the level of Assistant Professor (or equivalent) are eligible to be named by the applicant organization as the PI. Each investigator may be named on only one FY24 LRP IPA application as a PI.

Period of Performance
Awards supported with FY24 funds will be made no later than September 30, 2025.

It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

Grant Value
$5M is expected to be allotted to fund approximately five FY24 LRP IPA applications.

The anticipated total costs budgeted for the entire period of performance for an FY24 LRP IPA should not exceed $1M.